AnticipatedClinical trial: Optional / allowed
ADA Pathway to Stop Diabetes
American Diabetes Association (ADA) · Nonprofit
Source: American Diabetes Association (ADA) (curated) · View original posting ↗
Annual nomination-based cycle (one nominee per institution) — next round not yet posted.
- AwardWhat a single award can be worth — the funder's published per-award amount or floor–ceiling range.
- Up to $1.6M
- DeadlineFinal application due date.
- Not yet posted
- Letter of intentDue date for the letter of intent (a short pre-application some funders require or request before the full proposal).
- —
- MechanismNIH activity code — the grant type (R01 research project, R21 exploratory, K series career development, F series fellowship, …).
- —
- DurationMaximum project period for a single award.
- 5 yr
- Expected awardsHow many awards the funder anticipates making under this opportunity.
- —
- Funding cycleHow often the program accepts applications (annual, multiple cycles per year, rolling, or one-time).
- Recurring (annual)
- Open dateWhen applications open (or opened).
- —
- Total fundingThe overall pool the funder expects to commit across ALL awards under this opportunity — not what one project receives.
- $1.6M total
- Clinical trialWhether proposed projects must, may, or must not include a clinical trial.
- Optional / allowed
Early careerHigher educationNonprofit
Research areas
Basic mechanisms & biologyTherapeutics & drug discoveryTraining & career development
Auto-classified from the title and description (keyword-based) — may be imperfect.
Description
Flagship long-horizon awards giving exceptional early-career and accelerator-stage scientists sustained, flexible funding to pursue transformative diabetes research. Curated entry; verify current terms at the program page.
This funder has no public API, so the entry is manually curated — confirm current amounts, deadlines, and eligibility on the source page.